The global market for Poultry Diagnostics was estimated at US$480.3 Million in 2023 and is projected to reach US$878.8 Million by 2030, growing at a CAGR of 9.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Technological advancements have significantly improved the accuracy, speed, and convenience of poultry diagnostics. Innovations in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have enabled the rapid and precise detection of a wide range of pathogens, including viruses, bacteria, and parasites. The development of point-of-care diagnostic devices has facilitated on-site testing, providing immediate results and reducing the need for laboratory analysis. Advances in immunoassay technologies, such as enzyme-linked immunosorbent assay (ELISA), have improved the sensitivity and specificity of serological tests, enabling reliable detection of antibodies and antigens. Additionally, the integration of digital technologies and data analytics has enhanced the monitoring and management of poultry health, allowing for real-time tracking of disease outbreaks and informed decision-making. These technological innovations have transformed poultry diagnostics, making them more effective and accessible for farmers.
Technological advancements have significantly improved the accuracy, speed, and convenience of poultry diagnostics. Innovations in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have enabled the rapid and precise detection of a wide range of pathogens, including viruses, bacteria, and parasites. The development of point-of-care diagnostic devices has facilitated on-site testing, providing immediate results and reducing the need for laboratory analysis. Advances in immunoassay technologies, such as enzyme-linked immunosorbent assay (ELISA), have improved the sensitivity and specificity of serological tests, enabling reliable detection of antibodies and antigens. Additionally, the integration of digital technologies and data analytics has enhanced the monitoring and management of poultry health, allowing for real-time tracking of disease outbreaks and informed decision-making. These technological innovations have transformed poultry diagnostics, making them more effective and accessible for farmers.
What Are the Key Benefits of Poultry Diagnostics?
Poultry diagnostics offer numerous benefits that enhance the health and productivity of poultry flocks. Diagnostic tests for avian influenza, Newcastle disease, and infectious bronchitis are essential for early detection and control of these highly contagious diseases, preventing significant economic losses. Routine monitoring of flock health through diagnostics helps identify and manage common bacterial infections, such as Salmonella and Mycoplasma, ensuring the safety of poultry products. Diagnostic tools also play a crucial role in vaccination programs, verifying the efficacy of vaccines and monitoring the immune status of flocks. The primary benefits of poultry diagnostics include improved disease control, enhanced biosecurity, and optimized production efficiency, contributing to the overall sustainability and profitability of poultry farming.What Factors Are Driving the Growth in the Poultry Diagnostics Market?
The growth in the poultry diagnostics market is driven by several factors. The increasing prevalence of infectious diseases in poultry and the need for effective disease management are significant drivers, boosting the demand for advanced diagnostic tools. Technological advancements that enhance the accuracy, speed, and convenience of diagnostics are also propelling market growth. The rising awareness of animal welfare and the need for sustainable poultry production practices are driving the adoption of diagnostics that support early disease detection and preventive health measures. Additionally, the expansion of the poultry industry and the growing demand for high-quality poultry products are contributing to market growth. The increasing regulatory requirements for disease control and food safety are further boosting the demand for reliable poultry diagnostics. These factors, coupled with the increasing availability of innovative and cost-effective diagnostic solutions, are driving the sustained growth of the poultry diagnostics market.Key Insights:
- Market Growth: Understand the significant growth trajectory of the ELISA segment, which is expected to reach US$558.3 Million by 2030 with a CAGR of a 9.9%. The PCR segment is also set to grow at 8.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $125.3 Million in 2023, and China, forecasted to grow at an impressive 12.2% CAGR to reach $201.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Poultry Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Poultry Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Poultry Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Affinitech, Ltd., Agrobiotek Internacional (Honduras), Aquila Diagnostic Systems Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 23 Featured):
- Affinitech, Ltd.
- Agrobiotek Internacional (Honduras)
- Aquila Diagnostic Systems Inc.
- Biochek BV
- Biogal, Galed Labs. Acs Ltd.
- Bioingentech Biotechnologies Inc.
- Bioneer Corporation
- Bionote, Inc.
- Boehringer Ingelheim International GmbH
- Clementia Biotech
- DRG Instruments GmbH
- GD Animal Health
- Idexx Laboratories, Inc.
- Idvet
- Life Bioscience Pty Ltd.
- Megacor Diagnostik GmbH
- Nisseiken Co., Ltd.
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Ubio Biotechnology Systems Pvt. Ltd.
- Zoetis, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affinitech, Ltd.
- Agrobiotek Internacional (Honduras)
- Aquila Diagnostic Systems Inc.
- Biochek BV
- Biogal, Galed Labs. Acs Ltd.
- Bioingentech Biotechnologies Inc.
- Bioneer Corporation
- Bionote, Inc.
- Boehringer Ingelheim International GmbH
- Clementia Biotech
- DRG Instruments GmbH
- GD Animal Health
- Idexx Laboratories, Inc.
- Idvet
- Life Bioscience Pty Ltd.
- Megacor Diagnostik GmbH
- Nisseiken Co., Ltd.
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Ubio Biotechnology Systems Pvt. Ltd.
- Zoetis, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 164 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 480.3 Million |
Forecasted Market Value ( USD | $ 878.8 Million |
Compound Annual Growth Rate | 9.0% |
Regions Covered | Global |